Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in active rheumatoid arthritis previously treated with anti-TNFa
NCT00299546Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of golimumab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Feb 2006; status: completed.
02
Drugs
golimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00299546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299546.